Cointime

Download App
iOS & Android

Outlook Therapeutics

company
Funding Round
Post-IPO Equity
Money Raised
$ 25M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
GMS Holdings - Yes - Detail

Historical Financing

Announced Date Round Money Raised Investors
Dec 22, 2022 Post-IPO Debt $ 6.80M Detail
May 26, 2020 Post-IPO Equity $ 27.20M Syntone Ventures Detail
Jul 27, 2015 Series Unknown $ 31M Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc. Detail
Nov 5, 2018 Post-IPO Equity $ 20M Biolexis Detail
Nov 29, 2021 Post-IPO Equity $ 57.50M Detail
Jan 29, 2021 Post-IPO Equity $ 35M Detail
Feb 16, 2021 Post-IPO Equity $ 42.60M Detail
Sep 29, 2015 Series Unknown 0 Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc. Detail
Feb 24, 2020 Post-IPO Equity $ 10.20M Detail
May 14, 2018 Post-IPO Equity $ 15M GMS Tenshi Holdings Detail
May 13, 2016 IPO $ 35M Detail